Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by jojomarchon Nov 06, 2017 11:04am

93 Views

Post# 26911591

RE:Lung Cancer

Excellent post FredGoodWinson . Do you think it could be the next TLT trial ? With research like this going on and the actual human clinical results so far the TLT market cap should be 5 to 10 times greater . The public eye needs to be on this science . Roger get us off this exchange , it insults your intelligence and it insults PMH and the doctors involved .

GO TLT GO

GO RW GO

GLTA

Bullboard Posts

This junior mining stock offers billions in market exposure